European Journal of Clinical and Biomedical Sciences

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Discontinuation Patterns Among Women Using Jadelle Contraceptive Devices in a Tertiary Hospital in South-South Nigeria

Introduction: The Jadelle subdermal contraceptive implant is a widely used hormonal contraceptive consisting of two rods, each consisting of a Levonorgestrel-releasing core encased in thin-walled silicon-rubber tubing. Our study examined the prevalence and discontinuation patterns of Jadelle among women in a Southern Nigerian Hospital. Materials and Methods: A review of the discontinuation patterns among Jadelle contraceptive device users in the University of Uyo Teaching Hospital over 3 years was carried out. The Case files of all clients who used Jadelle implant over the period were retrieved and analyzed. Results: Out of 2,980 clients using different contraceptive methods during the study period, 231 clients (7.8%) used the Jadelle implant. Of the 198 (85.7%) case notes available, most (52%) of them were aged 30-34 years, had attained a tertiary level of education (50.4%), and were grand-multiparous (50%). Fifty-six (56.6%) percent of clients used Jadelle for birth spacing while 44.5% used it for limiting family sizes. The most common menstrual pattern at 24 months follow-up was Amenorrhea (50%). Sixty clients (30.3%) discontinued the method for reasons which include the desire for pregnancy (48.3%), side effects (25%), change of method (11.5%), and husbands` view (5%). Discontinuation was more among the younger clients less than 36 years (86.7%). Conclusion: The Jadelle contraceptive device is associated with a number of side effects, however, the major reason for discontinuation was the desire for pregnancy, followed by the complications arising from Jadelle use. There is a need for more detailed client and spousal counseling, especially on the side effects of Jadelle to reduce discontinuation due to them.

Contraception, Family Planning, Jadelle, Side Effects, Discontinuation

APA Style

Obinna Njoku, Matthias Gabriel Abah, Uduak Solomon Ocheche, Emmanuel Columba Inyangetoh, Mbereobong Saturday Etuk. (2023). Discontinuation Patterns Among Women Using Jadelle Contraceptive Devices in a Tertiary Hospital in South-South Nigeria. European Journal of Clinical and Biomedical Sciences, 9(2), 22-27. https://doi.org/10.11648/j.ejcbs.20230902.12

ACS Style

Obinna Njoku; Matthias Gabriel Abah; Uduak Solomon Ocheche; Emmanuel Columba Inyangetoh; Mbereobong Saturday Etuk. Discontinuation Patterns Among Women Using Jadelle Contraceptive Devices in a Tertiary Hospital in South-South Nigeria. Eur. J. Clin. Biomed. Sci. 2023, 9(2), 22-27. doi: 10.11648/j.ejcbs.20230902.12

AMA Style

Obinna Njoku, Matthias Gabriel Abah, Uduak Solomon Ocheche, Emmanuel Columba Inyangetoh, Mbereobong Saturday Etuk. Discontinuation Patterns Among Women Using Jadelle Contraceptive Devices in a Tertiary Hospital in South-South Nigeria. Eur J Clin Biomed Sci. 2023;9(2):22-27. doi: 10.11648/j.ejcbs.20230902.12

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Hoffman BL, Schorge JO, Halvarson LM, Bradshaw KD: Contraception and sterilization in Williams Gynecology. 2nd Edition. 2012: 132-164.
2. Abah M. G, Bassey E. A, Edu E. B, Ovie O. D. Unsafe abortion among secondary school girls in a local authority in South-south Nigeria. International Journal of Reproduction, Contraception, Obstetrics and Gynaecology. 2020; 9: 3547-56.
3. Abah M. G, Bassey, E. A, Ekwere T. A, Motilewa O. O, Edu B. E, Abah I. G., Ocheche, U.S. Contraceptive Preferences and Trends Among New Acceptors in a Southern Nigerian Tertiary Hospital. Tropical Journal of Obstetrics and Gynaecology. 2023; 39 (3): 57-64.
4. Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev. 2007 Jul 18; 2007 (3): CD001326. doi 10.1002/14651858.CD001326.pub2. PMID: 17636668; PMCID: PMC7025801.
5. Brache V, Fandes A, Alvarez F, Cochon L. Non-menstrual adverse events during use of implementable contraceptives for women: data from clinical trials. Contraception 2002; 65: 63-74.
6. WHO, UNICEF, UNFPA, UNPD, and World Bank Maternal mortality in 2013: estrules by WHO, UNICEF, UNFPA, UNPD and World Bank 2013.
7. Laphikanont W, Taneepanichskul S. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2006 Jun; 89 (6): 761-6. PMID: 16850674.
8. Hohmann H, Creimum, M. The Contraceptive Implant. Clinical Obstetrics and Gynecology. 2007; 50: 907-917. Available at: https://doi.org/10.1097/GRF.0b013e318159c2f6
9. Sivin I, Nash H, Waldman S. Jadelle Levonorgestrel Rod Implants: A Summary of Scientific Data and Lessons Learned from Programmatic Experience. Available at: http://respondproject.org/pages/files/4_result_areas/Result_1_Global_Learning/LA_PM_CoP/june2009-launch/Jadelle-Levonorgestrel-Rod-Implants.pdf
10. Kahlenborn C, Peck R, Severs WB. Mechanism of action of levonorgestrel emergency contraception. Linacre Q. 2015 Feb; 82 (1): 18-33. doi: 10.1179/2050854914Y.0000000026.
11. Thaxton, L.; Lavelanet, A. Systematic review of efficacy with extending contraceptive implant duration. Int. J. Gynaecol. Obstet. 2019; 44: 2–8.
12. Glasier A, Scorer J, Bigrigg A. Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. Journal of Family Planning and Reproductive Health Care 2008; 34: 213-217.
13. Rocca ML, Palumbo AR, Visconti F, Di Carlo C. Safety and Benefits of Contraceptives Implants: A Systematic Review. Pharmaceuticals. 2021; 14 (6): 548. Available at: https://doi.org/10.3390/ph14060548
14. Family Planning: A global handbook for providers evidence-based guidance developed through worldwide collaboration A WHO Family Planning cornerstone 2007. 109-130.
15. Jacostem R, Stanley H. Contraceptive implants: providing better choice to meet growing family demand. Glos Health Sci Pract. 2013; 1 (1): 11-17.
16. Enymdali CE, Kassot. Jadelle Subdermal Implants. Preliminary experience in a teaching hospital in the Niger Delta Region of Nigeria. Niger J. Med. 2011, 20 (2): 270-274.
17. Madugu, N., Abdul M., Bawa U. and Kolawole B. Update of hormonal implants contraceptive in Zaria, Northern Nigeria. Open Journal of Obstetrics and Gynaecology, 2015; 5: 268-273.
18. Hubacher D, Olawo A, Manduku C., Kiarie J. Factors associated with uptake of subdermal contraceptive implants in a young Kenyan population. Contraception. 2011; 84 (4), 413- 417 doi: 10.1016/j.contraception.2011.02.007. pmid:21920198.
19. Sey-Sawo J, Tunkara-Bah H. Jadelle implant acceptance amongst women in Western Health Region 1, The Gambia. International Journal of Africa Nursing Sciences 2018; 9: 38–41.
20. Abasiattai, AM, Utuk NM., EC. Subdermal contraceptive implants: Profile of acceptors at the University of Uyo Teaching Hospital Uyo Nigeria. International Journal of Gynaecology, Obstetrics and Neonatal Care, 2014, II, 9-13.
21. Pam VC, Mutihir JT, Nyango DD, Shambe I, Egbodo CO, Karshima JA. Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos, Nigeria. Niger Med J. 2016 Nov-Dec; 57 (6): 314-319. doi: 10.4103/0300-1652.193855. PMID: 27942097; PMCID: PMC5126742.
22. Eva G, Ngo TD. MSI mobile outreach services: retrospective evaluations from Ethiopia, llyanmar, Pakistan, Sierra Leone, and Vietnam. London: Marie Stopes International 2010.
23. Inyang-Etoh EC, Akpan AS. Side effect profile of Jadelle implant in Nigerian women during the first 12 months of usage. Int J Reprod Contracept Obstet Gynecol. 2016; 5: 1461-6.
24. Sivin J, Alvarez F, Mishell Dr Jr, Darney P, Wan L, Brache V, et al. Contraception with two Levernogestrel rod implants. A 5-year study in the United States and Dominican Republic. Contraception 1998; 58: 275-82.
25. Barclay L, ACOG Updates Contraceptive guidelines. Obstet Gynecol. 2015; 126: 685-686.
26. Ali M. M, Cleland J, Shah I. H. Causes and consequences of contraceptive discontinuation: evidence from 60 demographic and health surveys [Internet]. Geneva: World Health Organization; 2012.
27. Shaikh IB, Jafry SIA, Zulfiqar Hyder Naqvi SM, Firdous SN. Knowledge, attitude and practices regarding implants among women of childbearing age. J Pak Med Assoc. 2021 Mar; 71 (3): 993-996. doi: 10.47391/JPMA.971. PMID: 34057960.